We’re excited to announce the opening of a new clinical site at CHU de Reims, France, for our on-going European “Valvosoft® Pivotal Study”! 
This new site will help us continue evaluating the safety and effectiveness of our non-invasive ultrasound therapy (NIUT) for the treatment of Aortic Stenosis, which has the potential to transform the way we approach patient care. Our team of expert clinicians and researchers are committed to ensuring that our clinical investigations are conducted in reference to the highest standards, and we look forward to advancing the field of medicine through our work.
Thanks to CHU de Reims, Dr. Laurent Faroux, Pr. Damien Metz and their team for their partnership and support, and to all the patients who have participated in our clinical investigations thus far. Your contributions are crucial to advancing medical knowledge and improving patient outcomes.
CHU de Reims #HEGP, AP-HP, Assistance Publique – Hôpitaux de Paris, Physics for Medicine Paris, #InstitutLangevin, CNRS – Centre national de la recherche scientifique, ESPCI Paris – PSL, Inserm RHU STOP AS #HeartValveDisease #FocusedUltrasound #MedTech #AorticStenosis #HeartValveDisease #Medtech #FrenchCare #Health20